NCT05539196 - A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2023

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2029

Conditions

Movement DisordersNeurologyParkinsons Disease

Interventions

DEVICE

Exablate Pallidotomy, Unilateral

Unilateral pallidotomy using focused ultrasound for the treatment of Parkinson's Disease with medication-refractory moderate to severe motor complications.

Trial Locations (5)

10065

RECRUITING

Weill Cornell Medicine, New York

19106

RECRUITING

University of Pennsylvania, Philadelphia

21201

RECRUITING

University of Maryland, Baltimore, Baltimore

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

674-0064

RECRUITING

Ohnishi Neurological Center, Akashi